Biotech Company
ProMIS Neurosciences Inc. (TSX:PMN, OTCQB:ARFXF, Forum) on Monday announced the appointment of Rudolph Tanzi, Ph.D, to the Company's scientific advisory board (SAB). He is also the Joseph P. and Rose F. Kennedy Professor of Neurology at Harvard University and Vice-Chair of Neurology, Director of the Genetics and Aging Research Unit, and Co-Director of the Henry and Allison McCance Center for Brain Health at Massachusetts General Hospital.
To read more about him, click
here.
ProMIS made news recently when it released its year-to-date overview for 2018 and outlook on priorities for advancing its programs.
FULL DISCLOSURE: ProMIS Neurosciences Inc.is a client of Stockhouse Publishing.